America's Best Contacts & Eyeglasses (EYE) - Kewajiban jangka dawa marang modal

America's Best Contacts & Eyeglasses - logo grafis emiten EYE

The National Vision Holdings (EYE) price chart helps assess the business's debt load, where transparent management is effectively implementing an omnichannel approach. National Vision Holdings (EYE) leverages its leadership status in the affordable optics segment and its network of proprietary laboratories, achieving a metric of 0.63. Management is currently restructuring operations following the termination of a key agreement with an insurer, striving to accelerate the development of autonomous retail outlets to restore investor confidence.

nationalvision.com (EYE): Rasio utang jangka dawa marang ekuitas saka 04.07.2022 nganti 01.11.2026
Produk mawa merek National Vision Corp

The management competence of National Vision Holdings (EYE) in cost optimization and the execution of its network expansion strategy correlates directly with the efficiency of its debt load management. By analyzing this chart of the long-term debt-to-equity ratio, an investor assesses the proportion of liabilities with a maturity of over one year relative to equity, which allows for the determination of the balance between financial leverage and the business's resilience to systemic risks.

Perusahaan pesaing

HCA: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal THC|FMS - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal SOLV (Solventum Corporation)|Utang jangka dawa marang modal encompasshealth.com EHC|UHS: Rasio utang jangka dawa marang ekuitas|DaVita HealthCare Partners - Rasio silihan jangka dawa marang modal|RadNet Corp (RDNT) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Option Care Corp|SGRY (Surgery Partners, Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal premierinc.com PINC|Utang jangka dawa marang ekuitas Progyny (PGNY)|Ardent Health - Rasio utang jangka dawa marang modal|Select Medical Corp - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal ASTH (Astrana Corp)|MD - Utang jangka dawa marang ekuitas|USPH (U.S. Physical Therapy) - Rasio utang jangka dawa marang modal|PNTG: Utang jangka dawa marang modal|Organogenesis Holdings Inc. (ORGO) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas NUTX|AUNA (Auna Corp) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang modal SBC|Rasio tanggungan utang jangka dawa marang modal evolus.com|Utang jangka dawa marang ekuitas Community Health Systems, Inc. CYH|The Beauty Health Company (SKIN) - Kewajiban jangka dawa marang modal|MDWD - Utang jangka dawa marang ekuitas|BTMD (Biote Corporation) - Rasio utang jangka dawa marang modal|JYNT: Utang jangka dawa marang modal|docgo.com (DCGO) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas P3 Health Partners, Inc.|Utang jangka dawa marang ekuitas GANX|Rasio utang jangka dawa marang ekuitas EUDA (EUDA Health)|BMGL (baselmedical.com) - Koefisien utang jangka dawa marang modal|CollPlant Biotechnologies Ltd. - Rasio utang jangka dawa marang ekuitas|cuprina.com.sg - Utang jangka dawa marang ekuitas|Concord Medical - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal American Shared Hospital Services Inc AMS|MEDIROM Healthcare Group Inc (MRM) - Utang jangka dawa marang ekuitas|ALBT - Rasio tanggungan utang jangka dawa marang modal|DHAI (DIH Holding US, Inc.) - Utang jangka dawa marang modal|carmellcosmetics.com (XAGE) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas NewGenIvf (NIVF)|ATIP - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas CareMax Medical Group CMAX|KDLY: Rasio utang jangka dawa marang modal|MODV: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal NVOS (novointegrated.com)|SSY: Utang jangka dawa marang modal|IMAC Holdings Inc - Koefisien utang jangka dawa marang modal